Effects of early treatment with zofenopril in patients with myocardial infarction and metabolic syndrome: the SMILE Study

References

• AmbrosioniEBorghiCMagnaniBThe effect of the angiotensin-converting-enzyme inhibitor zofenopril on mortality and morbidity after anterior myocardial infarction. The Survival of Myocardial Infarction Long-Term Evaluation (SMILE) Study InvestigatorsN Engl J Med19953328057990904
   PubMed Web of Science ®Google Scholar
• BorghiCAmbrosioniESurvival of Myocardial Infarction Long-term Evaluation-2 Working PartyDouble-blind comparison between zofenopril and lisinopril in patients with acute myocardial infarction: results of the Survival of Myocardial Infarction Long-term Evaluation-2 (SMILE-2) studyAm Heart J200314580712514658
   PubMed Web of Science ®Google Scholar
• BorghiCBacchelliSDegliEspostiDA review of the angiotensin-converting enzyme inhibitor, zofenopril, in the treatment of cardiovascular diseasesExpert Opin Pharmacother2004519657715330734
   PubMed Web of Science ®Google Scholar
• BorghiCBacchelliSEspostiDDSMILE StudyEffects of the early ACE inhibition in diabetic nonthrombolyzed patients with anterior acute myocardial infarctionDiab Care20032618628
   PubMed Web of Science ®Google Scholar
• BorghiCMarinoPZardiniPShort- and long-term effects of early fosinopril administration in patients with acute anterior myocardial infarction undergoing intravenous thrombolysis: results from the Fosinopril in Acute Myocardial Infarction Study. FAMIS Working PartyAm Heart J19981362132259704681
   PubMed Web of Science ®Google Scholar
• DalyCAFoxKMRemmeWJEUROPA InvestigatorsThe effect of perindopril on cardiovascular morbidity and mortality in patients with diabetes in the EUROPA study: results from the PERSUADE substudyEur Heart J20052613697815860521
   PubMed Web of Science ®Google Scholar
• DonnellyRManningGAngiotensin-converting enzyme inhibitors and coronary heart disease preventionJ Renin Angiotensin Aldosterone Syst20078132217487822
   PubMed Web of Science ®Google Scholar
• EckelRHGrundySMZimmetPZThe metabolic syndromeLancet200536514152815836891
   PubMed Web of Science ®Google Scholar
• FordESGilesWHDietzWHPrevalence of the metabolic syndrome among US adults: findings from the third National Health and Nutrition Examination SurveyJAMA2002287356911790215
   PubMed Web of Science ®Google Scholar
• FrascarelliSGhelardoniSRonca-TestoniSZucchiRCardioprotective effect of zofenopril in perfused rat heart subjected to ischemia and reperfusionJ Cardiovasc Pharmacol200443294914716220
   PubMed Web of Science ®Google Scholar
• GrundySMCleemanJIMerzCNCoordinating Committee of the National Cholesterol Education ProgramImplications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III GuidelinesJ Am Coll Cardiol2004447203215358046
   PubMed Web of Science ®Google Scholar
• GustafssonITorp-PedersenCKoberLEffect of the angiotensin-converting enzyme inhibitor trandolapril on mortality and morbidity in diabetic patients with left ventricular dysfunction after acute myocardial infarction. Trace Study GroupJ Am Coll Cardiol19993483910399995
   PubMed Web of Science ®Google Scholar
• HOPE Study GroupEffects of ramipril on cardiovascular and microvascular outcomes in people with diabetes mellitus: results of the HOPE study and MICRO-HOPE substudy. Heart Outcomes Prevention Evaluation Study InvestigatorsLancet2000355253910675071
   PubMed Web of Science ®Google Scholar
• HuGQiaoQTuomilehtoJDECODE Study GroupPrevalence of the metabolic syndrome and its relation to all-cause and cardiovascular mortality in nondiabetic European men and womenArch Intern Med200416410667615159263
   PubMed Web of Science ®Google Scholar
• HuntKJResendezRGWilliamsKSan Antonio Heart StudyNational Cholesterol Education Program versus World Health Organization metabolic syndrome in relation to all-cause and cardiovascular mortality in the San Antonio Heart StudyCirculation20041101251715326061
   PubMed Web of Science ®Google Scholar
• LevantesiGMacchiaAMarfisiRGISSI-Prevenzione InvestigatorsMetabolic syndrome and risk of cardiovascular events after myocardial infarctionJ Am Coll Cardiol2005462778316022955
   PubMed Web of Science ®Google Scholar
• MullerCReddertAWassmannSInsulin-like growth factor induces up-regulation of AT(1)-receptor gene expression in vascular smooth muscle cellsJ Renin Angiotensin Aldosterone Syst20001273711881037
   PubMedGoogle Scholar
• National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III)Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final reportCirculation2002106314342112485966
   PubMed Web of Science ®Google Scholar
• NinomiyaJKL’ItalienGCriquiMHAssociation of the metabolic syndrome with history of myocardial infarction and stroke in the Third National Health and Nutrition Examination SurveyCirculation200410942614676144
   PubMed Web of Science ®Google Scholar
• NissenSETuzcuEMLibbyPfor CAMELOT InvestigatorsEffect of antihypertensive agents on cardiovascular events in patients with coronary disease and normal blood pressure: the CAMELOT study: a randomized controlled trialJAMA200429222172515536108
   PubMed Web of Science ®Google Scholar
• NormanGRStreinerDLBiostatisticsThe bare essentials20002Hamilton, CanadaB.C. Decker Inc.13944
   Google Scholar
• PrasadAQuyyumiAARenin-angiotensin system and angiotensin receptor blockers in the metabolic syndromeCirculation200411015071215364819
   PubMed Web of Science ®Google Scholar
• WalshJTBatinPDHawkinsMVentricular dilatation in the absence of ACE inhibitors: influence of haemodynamic and neurohormonal variables following myocardial infarctionHeart19998133910220542
   PubMed Web of Science ®Google Scholar
• ZellerMStegPGRavisyJObservatoire des Infarctus de Cote-d’Or Survey Working GroupPrevalence and impact of metabolic syndrome on hospital outcomes in acute myocardial infarctionArch Intern Med20051651192815911735
   PubMedGoogle Scholar
• ZhangCKnudsonJDSettySCoronary arteriolar vasoconstriction to angiotensin II is augmented in prediabetic metabolic syndrome via activation of AT1 receptorsAm J Physiol Heart Circ Physiol2005288H2154H6215653764
   PubMed Web of Science ®Google Scholar
• ZuanettiGLatiniRMaggioniAPEffect of the ACE inhibitor lisinopril on mortality in diabetic patients with acute myocardial infarction: data from the GISSI-3 studyCirculation1997964239459416888
   PubMed Web of Science ®Google Scholar